Tags

Type your tag names separated by a space and hit enter

Long-term follow-up of cryosurgery of basal cell carcinoma of the eyelid.
J Am Acad Dermatol. 1997 May; 36(5 Pt 1):742-6.JA

Abstract

BACKGROUND

Basal cell carcinoma (BCC) is the most common malignant tumor of the eyelid and its incidence is increasing. It remains to be established which is the best treatment in terms of safety and cost-effectiveness.

OBJECTIVE

Our purpose was to analyze the long-term treatment results and possible side effects of cryosurgery of eyelid BCC.

METHODS

During the last 14 years 219 patients (222 tumors) treated for eyelid BCC with cryosurgery were followed up prospectively for up to 10 years.

RESULTS

The tumors cleared completely after treatment in all patients with no recurrence observed to date. Ninety-two patients were followed up for 5 years or more. Complications were few and minor. In 26 treated eyelids conjunctival overgrowth was noted.

CONCLUSIONS

We conclude that cryosurgery of BCC of the eyelid has a high cure rate, is cost-effective, and is well tolerated.

Links

Publisher Full Text

Authors+Show Affiliations

Lindgren G
Department of Ophthalmology Göteborg University, Sahlgrenska Hospital, Sweden.
Larkö O
No affiliation info available

MeSH

AdultAgedAged, 80 and overCarcinoma, Basal CellCryosurgeryEyelid NeoplasmsFemaleFollow-Up StudiesHumansMaleMiddle AgedProspective Studies

Pub Type(s)

Journal Article

Language

eng

PubMed ID

9146537

Citation

Lindgren, G, and O Larkö. "Long-term Follow-up of Cryosurgery of Basal Cell Carcinoma of the Eyelid." Journal of the American Academy of Dermatology, vol. 36, no. 5 Pt 1, 1997, pp. 742-6.
Lindgren G, Larkö O. Long-term follow-up of cryosurgery of basal cell carcinoma of the eyelid. J Am Acad Dermatol. 1997;36(5 Pt 1):742-6.
Lindgren, G., & Larkö, O. (1997). Long-term follow-up of cryosurgery of basal cell carcinoma of the eyelid. Journal of the American Academy of Dermatology, 36(5 Pt 1), 742-6.
Lindgren G, Larkö O. Long-term Follow-up of Cryosurgery of Basal Cell Carcinoma of the Eyelid. J Am Acad Dermatol. 1997;36(5 Pt 1):742-6. PubMed PMID: 9146537.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Long-term follow-up of cryosurgery of basal cell carcinoma of the eyelid. AU - Lindgren,G, AU - Larkö,O, PY - 1997/5/1/pubmed PY - 1997/5/1/medline PY - 1997/5/1/entrez SP - 742 EP - 6 JF - Journal of the American Academy of Dermatology JO - J Am Acad Dermatol VL - 36 IS - 5 Pt 1 N2 - BACKGROUND: Basal cell carcinoma (BCC) is the most common malignant tumor of the eyelid and its incidence is increasing. It remains to be established which is the best treatment in terms of safety and cost-effectiveness. OBJECTIVE: Our purpose was to analyze the long-term treatment results and possible side effects of cryosurgery of eyelid BCC. METHODS: During the last 14 years 219 patients (222 tumors) treated for eyelid BCC with cryosurgery were followed up prospectively for up to 10 years. RESULTS: The tumors cleared completely after treatment in all patients with no recurrence observed to date. Ninety-two patients were followed up for 5 years or more. Complications were few and minor. In 26 treated eyelids conjunctival overgrowth was noted. CONCLUSIONS: We conclude that cryosurgery of BCC of the eyelid has a high cure rate, is cost-effective, and is well tolerated. SN - 0190-9622 UR - https://www.unboundmedicine.com/medline/citation/9146537/Long_term_follow_up_of_cryosurgery_of_basal_cell_carcinoma_of_the_eyelid_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0190-9622(97)80328-3 DB - PRIME DP - Unbound Medicine ER -